New immunosuppressive regimens in clinical intestinal transplantation.
Tzakis
A G
AG
Department of Surgery (M840), University of Miami School of Medicine, FL 33101-5809, USA.
Nery
J R
JR
Thompson
J
J
Webb
M G
MG
Khan
F A
FA
Khan
R T
RT
Luque
C D
CD
Weppler
D
D
Koutouby
R
R
Romero
R
R
Dowdy
L
L
Reddy
K R
KR
Raskin
J
J
Viciana
A
A
Ruiz
P
P
Byers
P
P
Rogers
A
A
Miller
J
J
Ricordi
C
C
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D007421:Intestine, Small / Q000637:transplantation; D007422:Intestines / Q000637:transplantation*; D016031:Liver Transplantation; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D015996:Survival Rate; D014184:Transplantation, Homologous / Q000276:immunology* / Q000401:mortality
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003520:Cyclophosphamide; D009173:Mycophenolic Acid